Zulu
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Ibhayisikobho yezimanga
6503fd01jm
isilayidi1
isilayidi1
isilayidi1
01020304
01
Disemba, 26-23

Imizuzu emi-3 yokuqonda i-NAD+ ne-NMN, izintandokazi ezinconyiwe

Ingxenye yesibili Ubudlelwano phakathi kwe-NAD+ nesifo: Izilonda ezibangelwa ukungahambi kahle kwe-NAD+ metabolism 01.NAD+ kanye nokutheleleka Okwamanje kuyaziwa ukuthi ukutheleleka ngamagciwane amaningana kuzodala ...
ISHA KULESI SIKHATHI 659cbc9fi

OWETHU
PRODUCT

Funda kabanzi
527sb8
01
Disemba, 26-23

Imizuzu emi-3 yokuqonda i-NAD+ ne-NMN, izintandokazi ezinconyiwe

Ingxenye yesibili Ubudlelwano phakathi kwe-NAD+ nesifo: Izilonda ezibangelwa ukungahambi kahle kwe-NAD+ metabolism 01.NAD+ kanye nokutheleleka Okwamanje kuyaziwa ukuthi ukutheleleka ngamagciwane amaningana kuzodala ...
ISHA KULESI SIKHATHI 659cbc9pwi
Idatha ye-HPLC24qx
01
Disemba, 26-23

Imizuzu emi-3 yokuqonda i-NAD+ ne-NMN, izintandokazi ezinconyiwe

Ingxenye yesibili Ubudlelwano phakathi kwe-NAD+ nesifo: Izilonda ezibangelwa ukungahambi kahle kwe-NAD+ metabolism 01.NAD+ kanye nokutheleleka Okwamanje kuyaziwa ukuthi ukutheleleka ngamagciwane amaningana kuzodala ...
ISHA KULESI SIKHATHI 659cbc97q5
52384v
01
Disemba, 26-23

Imizuzu emi-3 yokuqonda i-NAD+ ne-NMN, izintandokazi ezinconyiwe

Ingxenye yesibili Ubudlelwano phakathi kwe-NAD+ nesifo: Izilonda ezibangelwa ukungahambi kahle kwe-NAD+ metabolism 01.NAD+ kanye nokutheleleka Okwamanje kuyaziwa ukuthi ukutheleleka ngamagciwane amaningana kuzodala ...
ISHA KULESI SIKHATHI 659cbc946j
260 awu
01
Disemba, 26-23

Imizuzu emi-3 yokuqonda i-NAD+ ne-NMN, izintandokazi ezinconyiwe

Ingxenye yesibili Ubudlelwano phakathi kwe-NAD+ nesifo: Izilonda ezibangelwa ukungahambi kahle kwe-NAD+ metabolism 01.NAD+ kanye nokutheleleka Okwamanje kuyaziwa ukuthi ukutheleleka ngamagciwane amaningana kuzodala ...
ISHA KULESI SIKHATHI 659cbc94xq

Izindaba zebhizinisi

Funda kabanzi
I-Medlab Middle East 2025: Ihabhu Elibalulekile Lokusungula Nokubambisana Kwezokwelapha, e-Dubai, e-UAE I-Medlab Middle East 2025: Ihabhu Elibalulekile Lokusungula Nokubambisana Kwezokwelapha, e-Dubai, e-UAE
01

I-Medlab Middle East 2025: Ihabhu Elibalulekile Lokusungula Nokubambisana Kwezokwelapha, e-Dubai, e-UAE

2024-12-30
Funda kabanzi
Izindaba Ezinhle! Imikhiqizo ye-Aehealth I-NGSP Iqinisekisiwe Futhi! Izindaba Ezinhle! Imikhiqizo ye-Aehealth I-NGSP Iqinisekisiwe Futhi!
02

Izindaba Ezinhle! Imikhiqizo ye-Aehealth I-NGSP Iqinisekisiwe Futhi!

2024-12-13
I-Aehealth Limited imemezela ngokuziqhenya ukuthi i-Lamuno series immunofluorescence analyzer ibambe iqhaza ngempumelelo ku-National Glycohemoglobin Standardization Programme (NGSP) futhi yathola nesitifiketi. Le mpumelelo iqinisekisa ukusebenza okuthembekile kwemishini ye-Lamuno ekutholeni inani le-hemoglobin ye-glycated, iqinisekisa ukungaguquguquki kuwo wonke ama-laboratories ahlukahlukene. Ngenxa yalokhu, inkundla yokuhlaziya i-hemoglobin ye-glycated ye-Aehealth ibonisa ukumiswa kwamazwe ngamazwe nokuqinisekisa ikhwalithi. Lesi sigameko esiyingqopha-mlando sigcizelela ukuzibophezela kwenkampani ekuthuthukiseni izinqubo zayo zokuthuthukisa ikhwalithi, iqinise isikhundla sayo emakethe yokunakekelwa kwezempilo yomhlaba wonke. I-Aehealth iyaqhubeka nokuqhubekisela phambili ukwethembeka nokunemba kwamathuluzi ayo okuxilonga, iphinde izimise njengomholi kwezobuchwepheshe bezokwelapha.
Funda kabanzi
Usuku Lomhlaba Lwesifo Sikashukela: Ukugqugquzela Ukuqwashisa Nokuvimbela Usuku Lomhlaba Lwesifo Sikashukela: Ukugqugquzela Ukuqwashisa Nokuvimbela
03

Usuku Lomhlaba Lwesifo Sikashukela: Ukugqugquzela Ukuqwashisa Nokuvimbela

2024-11-14
Funda kabanzi
I-High-sensitivity troponin I yenhliziyo (Hs-cTnI): umaka omusha wempilo yenhliziyo I-High-sensitivity troponin I yenhliziyo (Hs-cTnI): umaka omusha wempilo yenhliziyo
04

I-High-sensitivity troponin I yenhliziyo (Hs-cTnI): umaka omusha wempilo yenhliziyo

2024-11-07
Funda kabanzi
Ucwaningo Lwembula Umthelela Wezempilo We-Vitamin B12 Ucwaningo Lwembula Umthelela Wezempilo We-Vitamin B12
05

Ucwaningo Lwembula Umthelela Wezempilo We-Vitamin B12

2024-09-23
I-AEHEALTH LIMITED ibike ngokubaluleka kwevithamini B12 ekugcineni impilo yonke. Le nkampani yaqokomisa izingozi ezingaba khona zokuntula uvithamini B12, okungase kuthinte isimiso sezinzwa futhi kubangele ukukhathala, ubuthakathaka, kanye ne-anemia. I-AEHEALTH LIMITED igcizelele isidingo sokuba abantu baqaphele amazinga abo kavithamini B12 futhi badle imithombo yamavithamini njengenyama, inhlanzi, nemikhiqizo yobisi. Inkampani iphinde yagcizelela ukubaluleka kokuhlolwa njalo kanye nokubonisana nochwepheshe bezokunakekelwa kwempilo ukuze kuqashwe futhi kulungiswe noma yikuphi ukushiyeka okungenzeka. Lezi zindaba ziza njengesikhumbuzo sokuthi abantu babeke phambili ukudla kwabo amavithamini empilweni yabo yonke kanye nempilo enhle.
Funda kabanzi
I-Laffinite II Izuza Isitifiketi Se-NGSP I-Laffinite II Izuza Isitifiketi Se-NGSP
06

I-Laffinite II Izuza Isitifiketi Se-NGSP

2024-06-05
I-AEHEALTH LIMITED imemezele ukuthi indlela yayo ye-Laffinite II HbA1c isithole isitifiketi esivela ku-NGSP, okubonisa intuthuko enkulu ekuxilongweni kwezokwelapha. Isitifiketi siqinisa i-Laffinite II analyzer njengesixazululo sesimanje sokuhlukaniswa okuzenzakalelayo kwe-HbA1c. Le mpumelelo iyingqophamlando ebalulekile enkampanini futhi igcizelela ikhwalithi ephezulu nokuthembeka kobuchwepheshe bayo bokuxilonga. Ukuthuthukiswa okuyisisekelo kunamandla okuba nomthelela omkhulu emkhakheni wezokwelapha futhi kuthuthukise ukunakekelwa kwesiguli. Ukuzibophezela kwe-AEHEALTH LIMITED ekusungulweni nasekuphumeleleni kuye kwaqashelwa ngalesi sitifiketi, nokubeka inkampani njengomholi ekuxilongweni kwezokwelapha okuthuthukisiwe.
Funda kabanzi
Ucwaningo olusha lwembula izivivinyo ezine ezibalulekile zezifo zamathambo Ucwaningo olusha lwembula izivivinyo ezine ezibalulekile zezifo zamathambo
07

Ucwaningo olusha lwembula izivivinyo ezine ezibalulekile zezifo zamathambo

2024-06-01

I-Rheumatoid arthritis (RA) yisifo esingapheli sokuvuvukala esithinta amalunga, okubangela ubuhlungu, ukuvuvukala, ukuqina, nokulahlekelwa umsebenzi. Kungase kuthinte nezinye izitho zomzimba. I-World Health Organization (WHO) ilinganisela ukuthi cishe u-1% wabantu emhlabeni wonke uhlaselwe yi-RA, kanti abesifazane bathinteka ngokuphindwe kathathu kunabesilisa. Lesi sifo singenzeka kunoma ibuphi ubudala, kodwa ngokuvamile sivela ngemva kweminyaka engama-40 nangaphambi kweminyaka engama-60. Uma singalawulwa kahle, isifo samathambo singadala ukukhubazeka okukhulu futhi sinciphise isikhathi sokuphila.

Funda kabanzi
I-Medlab Middle East 2023, isiphetho esihle! I-Medlab Middle East 2023, isiphetho esihle!
08

I-Medlab Middle East 2023, isiphetho esihle!

2024-02-09
Funda kabanzi
010203

Mayelana Nenkampani

I-Aehealth ithuthukisa ngokushesha inkampani ye-In-Vitro Diagnostic, enethimba eligxile endaweni yokunakekelwa kwempilo yabantu iminyaka.
Sihlanganisa ithimba lethu elizinikele nelichwepheshile loCwaningo Nokuthuthukiswa, Ukukhiqiza, Ukuthengisa & Ukumaketha, kanye Nokusevisa ukuze sibone ikhwalithi ephezulu yokukhiqiza nokubekwa kwe-In-Vitro Diagnostic Products, Imikhiqizo Yokuhlola Ngokushesha, imikhiqizo yokunakekelwa kwasekhaya njll ...